Case Reports in Pathology (Jan 2020)

Benign Histiocyte-Rich Pseudotumor Developing Postchemotherapy and Mimicking Residual Disease

  • Amrit P. Singh,
  • Glenn P. Murray,
  • Soumya Pandey

DOI
https://doi.org/10.1155/2020/4674103
Journal volume & issue
Vol. 2020

Abstract

Read online

Histiocyte-rich pseudotumors (HRPT) developing postchemoradiation therapy are a florid response to treatment and reparative change. Although these are benign processes, clinically and radiologically, these may mimic recurrent/relapsed disease. We describe a case of an adult male with history of diffuse large B-cell lymphoma (DLBCL), status postchemoradiation therapy, who developed HRPT at the site of original involvement, mimicking relapse of disease on positron emission tomography/computed tomography (PET/CT) imaging. This is one of the few reported cases of posttreatment HRPT. This entity is important to point out the limitations of PET/CT imaging in patients with lymphomas and metastatic disease and stresses the importance of an excisional biopsy for determining relapse and the need for further treatment.